Evogene Ltd. financial data

Symbol
EVGN on Nasdaq
Location
13 Gad Feinstein Street, Park Rehovot, Rehovot, Israel
State of incorporation
Israel
Fiscal year end
December 31
Latest financial report
20-F - Q4 2024 - Mar 27, 2025

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 6.51M shares -87.1%

Balance Sheet

Label TTM Value / Value Unit Change %
Assets 39.9M USD -22%
Liabilities 25M USD +11.6%